Adriamycin USP
3 Inquiries
23214-92-8
2026-07-10
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionHangzhou Dawn Ray Pharmaceutical Co.,Ltd, with approximately 67175 visits to its shop, is a reputable Manufactory that has been providing Adriamycin USP products for 5 years on ECHEMI.Basic Info
-
Product Name:
Doxorubicin
Other Name:5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,(8S-cis)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,(8S,10S)-;(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;14-Hydroxydaunomycin;Doxorubicin;NSC 123127;Doxil;Caelyx;Evacet;PK 2;Biotransdox;Rubex;Hydroxydaunomycin;Hydroxydaunorubicin;Rubidox;(7S,9S)-7-[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,1 1-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;Liporubicin;Oncodox;Caelix;Livatag;Ameisu;23257-17-2;24385-08-8;25311-50-6;29042-30-6;1394125-92-8
CAS No.:23214-92-8
Molecular Formula:C27H29NO11
InChIKeys:InChIKey=AOJJSUZBOXZQNB-TZSSRYMLSA-N
Molecular Weight:543.52
Exact Mass:543.52
EC Number:245-495-6
Categories:
Characteristics-
PSA:
206
XLogP3:-0.5
Appearance:orange to red powder
Density:1.61 g/cm3
Melting Point:204 °C
Flash Point:443.8ºC
Refractive Index:1.709
Water Solubility:H2O: soluble
Storage Conditions:-20°C
Vapor Pressure:2.5X10-23 at 25 deg C (est)
Toxicity:Peritoneal-rat LD50: 16 mg/kg; peritoneal-mouse LD50: 1.07 mg/kg
Flammability characteristics:Flammable; burning releases toxic nitrogen oxides and hydrogen chloride fumes
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Carcinogenicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H350 May cause cancer
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Commercially available doxorubicin hydrochloride lyophilized powder for injection should be stored in a dry place protected from sunlight. When stored at 15-30 deg C, Adriamycin RDF or Rubex has an expiration date of 3 or 2 years, respectively, following the date of manufacture. Doxorubicin hydrochloride conventional (nonencapsulated) injection should be protected from light and refrigerated at 2-8 deg C; when stored under these conditions, the injection is stable for 18 months
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
India
Pharmaceutical chemical Anti-tumor Adriamycin CAS23214-92-8 99% white powder Wuhan HHD
100 G Oct 27, 2023 
Pakistan
DOXORUBICIN
1 MT Feb 28, 2024
India
Doxorubicin API 99% white powder
5 KG Jul 5, 2023 Post an enquiry for this product
Hot Related Products
-
![(2Z)-2-[2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-2-oxoethylidene]butanedioic acid]( "(2Z)-2-[2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-2-oxoethylidene]butanedioic acid")
(2Z)-2-[2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-2-oxoethylidene]butanedioic acid -
![ADRIAMYCINONE]( "ADRIAMYCINONE")
ADRIAMYCINONE -
![Pirarubicin]( "Pirarubicin")
Pirarubicin -
![high quality Pirarubicin 99% transparent liquid KANBEI]( "high quality Pirarubicin 99% transparent liquid KANBEI")
high quality Pirarubicin 99% transparent liquid KANBEI -
![Pirarubicin 99% Dideu-5-00472 Dideu]( "Pirarubicin 99% Dideu-5-00472 Dideu")
Pirarubicin 99% Dideu-5-00472 Dideu -
![Pirarubicin cas 72496-41-4]( "Pirarubicin cas 72496-41-4")
Pirarubicin cas 72496-41-4
![(2Z)-2-[2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-2-oxoethylidene]butanedioic acid](https://file.echemi.com/fileManage/upload/goodpicture/20230901/benzene-1-3-5-tricarboxylic-acid_b20230901151849529.jpg "(2Z)-2-[2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-2-oxoethylidene]butanedioic acid")
